InsiderTrades

Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.

Accepted 2026-01-07 00:00:00 ET · period of report 2025-12-31 · accession 0001488774-26-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-01-07 2025-12-31 ZVRA Clifton R. LaDuane Former CFO, Treas F - Tax $8.96 -48.5K 143.5K -25% -$434.7K
D 2026-01-07 2025-12-31 ZVRA Clifton R. LaDuane Former CFO, Treas M - OptEx $0.00 +140.7K 192.0K +274% $0
DM 2026-01-07 2025-12-31 ZVRA Clifton R. LaDuane Former CFO, Treas M - OptEx $0.00 -140.7K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-31 F D 48,513 $8.96 143,515 D — — (F2) Shares withheld to cover withholding taxes for the vested restricted stock units and performance stock units.
2 Common Common Stock 2025-12-31 M A 140,667 $0.00 192,028 D — — (F1) Shares issued upon vesting of restricted stock units and performance stock units on December 31, 2025.
3 Derivative Restricted Stock Unit 2025-12-31 M D 86,667 $0.00 0 D — · — to — 86,667 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.
4 Derivative Restricted Stock Unit 2025-12-31 M D 34,000 $0.00 0 D — · — to — 34,000 Common Stock (F3) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.
5 Derivative Performance Stock Unit 2025-12-31 M D 20,000 $0.00 0 D — · — to — 20,000 Common Stock (F5) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. (F4) The vesting of all restricted stock units and performance stock units was accelerated upon the Reporting Person's departure from the Company on December 31, 2025.